Sai Life Sciences Limited has informed the Exchange about an Order dated 12th November 2025 passed by the Assistant Commissioner, Central Tax, Division-II (Pimpri), Pune-I Commissionerate u/s 74 of the CGST Act, 2017.
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has informed the stock exchange about an order dated 12th November 2025 passed by the Assistant Commissioner of Central Tax, Division-II (Pimpri), Pune-I Commissionerate under Section 74 of the CGST Act, 2017. Section 74 of the CGST Act typically deals with cases involving alleged non-payment, short-payment, or evasion of GST, including situations involving fraud, willful misstatement, or suppression of facts. The filing does not disclose the financial amount involved, the specific allegations, or the direction of the order (whether in favor of or against the company). Shareholders will need to await further details from the company regarding the impact of this order on its financials or operations.
This is a tax-related regulatory order, not a SEBI or securities market action. Until the quantum of any demand and the company's response (including any appeal) are disclosed, the impact on earnings and stock price remains unclear. Investors should watch for follow-up disclosures detailing the financial implications and the company's planned course of action.